Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.6 USD | -0.25% | -1.52% | -4.02% |
Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.02% | 184B | |
-0.75% | 108B | |
-2.97% | 67.82B | |
+4.48% | 51.05B | |
+9.09% | 44.67B | |
+3.60% | 41.78B | |
+3.12% | 26.78B | |
+4.10% | 26.59B | |
+15.43% | 25.86B | |
-0.94% | 25.03B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Transcript : Abbott Laboratories, Q3 2022 Earnings Call, Oct 19, 2022